These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 15685212)
1. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Kennard LE; Chumbley JR; Ranatunga KM; Armstrong SJ; Veale EL; Mathie A Br J Pharmacol; 2005 Mar; 144(6):821-9. PubMed ID: 15685212 [TBL] [Abstract][Full Text] [Related]
2. Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Choi BH; Choi JS; Yoon SH; Rhie DJ; Min DS; Jo YH; Kim MS; Hahn SJ Neuropharmacology; 2001 Sep; 41(4):443-53. PubMed ID: 11543764 [TBL] [Abstract][Full Text] [Related]
3. Fluoxetine attenuates the inhibitory effect of glucocorticoid hormones on neurogenesis in vitro via a two-pore domain potassium channel, TREK-1. Xi G; Zhang X; Zhang L; Sui Y; Hui J; Liu S; Wang Y; Li L; Zhang Z Psychopharmacology (Berl); 2011 Apr; 214(3):747-59. PubMed ID: 21069514 [TBL] [Abstract][Full Text] [Related]
4. K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Dong YY; Pike AC; Mackenzie A; McClenaghan C; Aryal P; Dong L; Quigley A; Grieben M; Goubin S; Mukhopadhyay S; Ruda GF; Clausen MV; Cao L; Brennan PE; Burgess-Brown NA; Sansom MS; Tucker SJ; Carpenter EP Science; 2015 Mar; 347(6227):1256-9. PubMed ID: 25766236 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells. Choi JS; Choi BH; Ahn HS; Kim MJ; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Sung KW; Hahn SJ Biochem Pharmacol; 2003 Dec; 66(11):2125-32. PubMed ID: 14609737 [TBL] [Abstract][Full Text] [Related]
7. TREK-1 isoforms generated by alternative translation initiation display different susceptibility to the antidepressant fluoxetine. Eckert M; Egenberger B; Döring F; Wischmeyer E Neuropharmacology; 2011; 61(5-6):918-23. PubMed ID: 21740918 [TBL] [Abstract][Full Text] [Related]
8. Selective Small Molecule Activators of TREK-2 Channels Stimulate Dorsal Root Ganglion c-Fiber Nociceptor Two-Pore-Domain Potassium Channel Currents and Limit Calcium Influx. Dadi PK; Vierra NC; Days E; Dickerson MT; Vinson PN; Weaver CD; Jacobson DA ACS Chem Neurosci; 2017 Mar; 8(3):558-568. PubMed ID: 27805811 [TBL] [Abstract][Full Text] [Related]
9. Polymodal Mechanism for TWIK-Related K+ Channel Inhibition by Local Anesthetic. Pavel MA; Chung HW; Petersen EN; Hansen SB Anesth Analg; 2019 Oct; 129(4):973-982. PubMed ID: 31124840 [TBL] [Abstract][Full Text] [Related]
10. Open channel block of Kv3.1 currents by fluoxetine. Sung MJ; Ahn HS; Hahn SJ; Choi BH J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934 [TBL] [Abstract][Full Text] [Related]
11. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Kecskeméti V; Rusznák Z; Riba P; Pál B; Wagner R; Harasztosi C; Nánási PP; Szûcs G Brain Res Bull; 2005 Sep; 67(1-2):126-32. PubMed ID: 16140171 [TBL] [Abstract][Full Text] [Related]
12. Dual effects of fluoxetine on mouse early embryonic development. Kim CW; Choe C; Kim EJ; Lee JI; Yoon SY; Cho YW; Han S; Tak HM; Han J; Kang D Toxicol Appl Pharmacol; 2012 Nov; 265(1):61-72. PubMed ID: 23022515 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of K+ currents of outer hair cells in guinea pig cochlea by fluoxetine. Bian JT; Yeh JZ; Aistrup GL; Narahashi T; Moore EJ Eur J Pharmacol; 2002 Oct; 453(2-3):159-66. PubMed ID: 12398899 [TBL] [Abstract][Full Text] [Related]
14. Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes. Magyar J; Szentandrássy N; Bányász T; Kecskeméti V; Nánási PP Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):203-10. PubMed ID: 15338108 [TBL] [Abstract][Full Text] [Related]
15. Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons. Choi JS; Choi BH; Ahn HS; Kim MJ; Han TH; Rhie DJ; Yoon SH; Jo YH; Kim MS; Hahn SJ Brain Res; 2004 Aug; 1018(2):201-7. PubMed ID: 15276879 [TBL] [Abstract][Full Text] [Related]
17. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Traboulsie A; Chemin J; Kupfer E; Nargeot J; Lory P Mol Pharmacol; 2006 Jun; 69(6):1963-8. PubMed ID: 16510561 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells. Hahn SJ; Choi JS; Rhie DJ; Oh CS; Jo YH; Kim MS Eur J Pharmacol; 1999 Feb; 367(1):113-8. PubMed ID: 10082273 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. Choi JS; Hahn SJ; Rhie DJ; Yoon SH; Jo YH; Kim MS J Pharmacol Exp Ther; 1999 Oct; 291(1):1-6. PubMed ID: 10490879 [TBL] [Abstract][Full Text] [Related]